MeSH D050723 - bone fractures
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D014947:Wounds and injuries
D050723:
Bone fractures
D000069076:Multiple fractures
0 Companies
0 Drugs
Success rate
D000071562:Avulsion fractures
0 Companies
0 Drugs
Success rate
D000072039:Fracture dislocation
0 Companies
0 Drugs
Success rate
D005264:Femoral fractures
0 Companies
0 Drugs
Success rate
D005596:Closed fractures
0 Companies
0 Drugs
Success rate
D005597:Open fractures
0 Companies
0 Drugs
Success rate
D005598:Spontaneous fractures
0 Companies
0 Drugs
Success rate
D005599:Ununited fractures
0 Companies
0 Drugs
Success rate
D006810:Humeral fractures
0 Companies
0 Drugs
Success rate
D011885:Radius fractures
0 Companies
0 Drugs
Success rate
D012253:Rib fractures
0 Companies
0 Drugs
Success rate
D012784:Shoulder fractures
0 Companies
0 Drugs
Success rate
D012887:Skull fractures
0 Companies
0 Drugs
Success rate
D013978:Tibial fractures
D014458:Ulna fractures
0 Companies
0 Drugs
Success rate
D015775:Stress fractures
0 Companies
0 Drugs
Success rate
D016103:Spinal fractures
0 Companies
0 Drugs
Success rate
D017759:Malunited fractures
0 Companies
0 Drugs
Success rate
D018460:Comminuted fractures
0 Companies
0 Drugs
Success rate
D050815:Compression fractures
0 Companies
0 Drugs
Success rate
D057068:Periprosthetic fractures
0 Companies
0 Drugs
Success rate
D057072:Intra-articular fractures
0 Companies
0 Drugs
Success rate
D064386:Ankle fractures
0 Companies
0 Drugs
Success rate
D000092443:Knee fractures
0 Companies
0 Drugs
Success rate
D000092482:Elbow fractures
0 Companies
0 Drugs
Success rate
D000092503:Wrist fractures
0 Companies
0 Drugs
Success rate
D000092504:Fibula fractures
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Zoledronic acid | Zoledronic Acid Accord | 2014-01-16 | |||
| Allergan | Zoledronic acid | Zoledronic acid Actavis | 2012-04-20 | |||
| Amgen | Denosumab | Xgeva | 2011-07-13 | $2,137 M | Q2/23-Q1/24 | |
| medac | Zoledronic acid | Zoledronic acid medac | 2012-08-03 | |||
| Mylan | Zoledronic acid | Zoledronic acid Mylan | 2012-08-23 | |||
| Phoenix Labs | Zoledronic acid | Zometa | 2001-03-20 | |||
| Teva | Zoledronic acid | Zoledronic acid Teva | 2012-08-16 |
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
15%2/13
Phase 3
45%5/11
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use